Response Rates to Anti–PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase

医学 突变 免疫疗法 癌症研究 遗传学 免疫系统 免疫学 生物 等位基因 微卫星 基因
作者
Cristina Valero,Mark Lee,Douglas R. Hoen,Ahmet Zehir,Michael F. Berger,Venkatraman Seshan,Timothy A. Chan,Luc G.T. Morris
出处
期刊:JAMA Oncology [American Medical Association]
卷期号:7 (5): 739-739 被引量:200
标识
DOI:10.1001/jamaoncol.2020.7684
摘要

IMPORTANCE: In June 2020, the US Food and Drug Administration approved the anti-programmed cell death 1 drug pembrolizumab for patients with malignant solid tumors of any histologic type with high tumor mutational burden (TMB; ≥10 mutations per megabase). The predictive value of this universal cutoff for high TMB is not well understood. OBJECTIVE: To examine the performance of a universal definition of high TMB in an independent cohort of patients with solid tumors treated with immune checkpoint inhibitors. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included 1678 patients at a single cancer referral center treated with immune checkpoint inhibitors from January 1, 2015, to December 31, 2018. Patients had 16 different cancer types and were treated with anti-programmed cell death 1 or programmed cell death ligand-1 immunotherapy. Tumors underwent next-generation sequencing. EXPOSURES: At least 1 dose of immune checkpoint inhibitors. MAIN OUTCOMES AND MEASURES: Best overall response to immune checkpoint inhibitor therapy. The hypothesis tested was formulated after data collection and prior to analysis. RESULTS: Of 1678 patients, 924 (55%) were male, and the median age was 64 years (interquartile range, 55-71 years). Using the universal cutoff of 10 mutations per megabase, 416 tumors (25%) were categorized as having high TMB. Across cancer types, the proportion of TMB-high tumors ranged from 0% of kidney cancers to 53% of melanomas (113 of 214). Tumors categorized as TMB-high had higher response rates compared with TMB-low tumors in only 11 of 16 cancer types. In the entire cohort, response rates increased with higher cutoffs for TMB-high categorization, reaching 41% (169 of 416) for TMB more than 10 and 56% (90 of 161) for TMB more than 18, the highest TMB decile. Response rates also increased with TMB percentile within cancer type. Using cancer-specific cutoffs, 457 tumors (27%) were categorized as TMB-high. Response rates within cancer type ranged from 4% for pancreatic cancer (1 of 26) to 70% for melanoma (46 of 66). Cancer-specific cutoffs were associated with numerically higher response rates for TMB-high compared with TMB-low tumors in 14 of 16 cancer types. CONCLUSIONS AND RELEVANCE: The data from this cohort study validate the finding of generally higher response rates following immune checkpoint inhibitor therapy for tumors with TMB of 10 or more mutations per megabase, across multiple cancer types. However, the predictive value of a universal numerical threshold for TMB-high was limited, owing to variability across cancer types and unclear associations with survival outcomes. Further investigation will help define cancer type-specific TMB cutoffs to guide decision-making.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Tuniverse_发布了新的文献求助10
刚刚
大方的向秋完成签到,获得积分10
1秒前
2秒前
2秒前
彭于晏的应助被liu采纳,获得10
2秒前
张123完成签到,获得积分10
3秒前
kgy发布了新的文献求助10
3秒前
河洛完成签到,获得积分10
3秒前
可耐的月饼完成签到 ,获得积分10
4秒前
充电宝的应助被俭朴钢铁侠采纳,获得10
4秒前
5秒前
伊子发布了新的文献求助10
6秒前
6秒前
柴胡完成签到,获得积分10
7秒前
敏感代云完成签到,获得积分10
8秒前
xiao发布了新的文献求助10
8秒前
yiwannian完成签到,获得积分10
8秒前
国度发布了新的文献求助10
10秒前
luoyun完成签到,获得积分10
10秒前
hsj发布了新的文献求助10
10秒前
Beatrice发布了新的文献求助30
11秒前
11秒前
bong完成签到 ,获得积分10
11秒前
mlll完成签到,获得积分10
11秒前
12秒前
yize发布了新的文献求助10
12秒前
烟花的应助被伊子采纳,获得10
13秒前
13秒前
儿儿完成签到,获得积分10
13秒前
脆条完成签到 ,获得积分10
14秒前
14秒前
Alan完成签到,获得积分10
14秒前
anj完成签到,获得积分10
14秒前
香蕉觅云的应助被小黑球采纳,获得10
14秒前
科研通AI2S的应助被lml采纳,获得10
16秒前
aki完成签到 ,获得积分10
16秒前
可爱的函函的应助被等风归采纳,获得10
16秒前
17秒前
17秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181888
求助须知:如何正确求助?哪些是违规求助? 9571628
关于积分的说明 21818887
捐赠科研通 7778145
什么是DOI,文献DOI怎么找? 3433528
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621